SPARC and obesity due to melanocortin 4 receptor deficiency: Considering that there is shared fundamental biology between SPARC’s role on adipose tissues during obesity and its role on cancer and bone microenvironments, it is possible that SPARC may affect cancer progression or bone remodeling by acting on resident myeloid cells.